Investor Files Securities Suit Over $952M Albireo Merger
An Albireo Pharma investor on Tuesday sued the biotechnology company and its board of directors in federal court, accusing them of violating securities laws by filing an incomplete and misleading recommendation...To view the full article, register now.
Already a subscriber? Click here to view full article